Approval · Notice of Compliance 19596 · 2017
SOVALDI: Notice of Compliance 19596
Issued July 28, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19596
- Date
- July 28, 2017
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Reclassification of three impurities (gs-331007, gs-606965, gs-607669) as speicified impurities
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOVALDI | Not yet assigned | — |
Medicinal ingredients
- SOFOSBUVIR 400 MG per TAB